NFKB1 and prostate carcinoma: Our previous studies, which demonstrate that inhibition of NF-κB and its antioxidant target, manganese superoxide dismutase (MnSOD), remarkably increase radiosensitivity of aggressive prostate cancer cells [5], [25], are consistent with the finding for this later mechanism.